Lupin names ex-Teva legal chief Brian Savage as president and CLO

what happened

Drugmaker Lupin has named Brian Savage its new president and chief legal officer, Moody's reports. He will head the group covering legal affairs, compliance and intellectual property work, operating out of New Jersey.

Savage comes from Teva Pharmaceuticals, where he spent years in senior roles, most recently as executive vice president and interim global chief legal officer. Earlier he ran the company's court strategy and acted as general counsel for the US generics unit. Before Teva he practised law at Dechert LLP. He holds a J.D. from Yale Law School and a bachelor's degree from the University of Pennsylvania, graduating summa cum laude.

Lupin's leaders, Vinita Gupta and Nilesh Gupta, said his industry knowledge and legal experience should help strengthen governance and adapt to changing regulation.

why it matters

For investors this is a routine management change rather than a financial event, since the report contains no figures. Still, drugmakers operate under complex regulation and intellectual property pressure, so a stronger legal function matters for long-term risk management.

tags

instruments